Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 6|pp. 5027–5037
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Back to articleFigure 6(6 of 7)
100%
Figure 6
Figure 6.PHN-20 inhibited the NLRP3 signaling and increased SIRT1 expression in hypoxia-treated PMECs. (A) Western blots of NLRP3, ASC, and SIRT1; (B) Analysis of the blots. (**, P<0.01 vs. control group; #, ##, P<0.05, 0.01 vs. hypoxia group).